Calculate the 4Ts score for heparin-induced thrombocytopenia (HIT) probability. Classifies patients into low, intermediate, or high pretest-probability bands.
The 4Ts Score Calculator estimates the pretest probability of heparin-induced thrombocytopenia (HIT), an immune-mediated complication of heparin exposure associated with thrombocytopenia and thrombosis. The score keeps the four original domains together: the degree of thrombocytopenia, the timing of platelet fall, thrombosis or other sequelae, and whether another cause could explain the picture.
Each component is scored 0, 1, or 2 points for a maximum total of 8. In practice, the strongest use of the 4Ts score is as a structured way to organize bedside review before the rest of the HIT workup is completed.
Validation studies consistently show a very high negative predictive value in the low-score band (0–3). Intermediate and high bands are best read as signals that the platelet trend, alternative causes, and the formal laboratory pathway deserve closer review rather than as a stand-alone treatment engine.
The 4Ts score is useful because thrombocytopenia in hospitalized patients has many competing explanations. This page keeps the original score components visible and converts them into one pretest-probability summary that can be compared with the platelet trend, the exposure timeline, and the rest of the thrombocytopenia evaluation.
Used that way, the calculator helps standardize documentation and reduce arithmetic mistakes without pretending the score by itself decides the laboratory or treatment pathway.
4Ts Score = Thrombocytopenia (0-2) + Timing (0-2) + Thrombosis (0-2) + oTher causes (0-2) Score Interpretation: • 0–3 = Low probability (~1-3% chance of HIT) • 4–5 = Intermediate probability (~14% chance of HIT) • 6–8 = High probability (~64-100% chance of HIT) Platelet Drop % = ((Baseline − Nadir) / Baseline) × 100
Result: 6 / 8 — High Probability
A patient with >50% platelet fall (2 pts), onset on day 7 of heparin (2 pts), no thrombosis (0 pts), and no other identifiable cause (2 pts) scores 6/8, placing them in the high-probability band. That result should be read as strong review context within the broader HIT pathway rather than as a stand-alone medication order.
HIT is a prothrombotic disorder caused by antibodies that recognize complexes of platelet factor 4 (PF4) and heparin. These antibodies activate platelets, leading to thrombocytopenia and thrombosis rather than bleeding as the dominant risk signal.
The score does not confirm HIT, but it remains useful because it organizes the earliest review around timing, platelet fall, thrombosis, and competing explanations. That makes it especially helpful before the laboratory pathway is complete.
The low-score band is mainly valuable for rule-out context. Intermediate and high bands should be read as signals that the rest of the HIT pathway deserves prompt attention. The score works best when it supports clinical communication and laboratory review rather than acting like a stand-alone treatment protocol.
Last updated:
This calculator applies the standard 4Ts pretest probability framework for suspected heparin-induced thrombocytopenia by scoring thrombocytopenia, timing, thrombosis or other sequelae, and alternative explanations from 0 to 2 each. The total is then grouped into the usual low-, intermediate-, and high-probability bands used to decide whether HIT is unlikely or whether confirmatory laboratory testing and heparin cessation should be considered.
The page is intended for pretest probability assessment, not for definitive HIT diagnosis. Its strongest clinical role is ruling out HIT when the score is low; intermediate and high scores still require PF4/heparin testing, functional confirmation when appropriate, and clinician judgment about anticoagulation management.
A score of 0–3 indicates a low pretest-probability band with a very high negative predictive value in validation studies. It is most useful for showing that HIT is less likely, not for replacing the rest of the thrombocytopenia review.
Calculate the 4Ts score whenever a patient on heparin develops an unexplained drop in platelet count, new thrombosis, skin necrosis at injection sites, or acute systemic reactions after heparin bolus.
No. The 4Ts score estimates pretest probability. Definitive diagnosis requires laboratory confirmation with an immunoassay (e.g., ELISA for PF4/heparin antibodies) and ideally a functional assay like the serotonin release assay (SRA).
HIT type I is a non-immune, benign, transient drop in platelets within the first 2 days of heparin, usually self-limiting. HIT type II is the immune-mediated form (what the 4Ts score assesses) that is clinically significant and associated with thrombosis.
An intermediate score means the picture is not cleanly low risk and deserves closer review. The next step still depends on the platelet trajectory, bleeding and thrombosis context, alternative explanations, and the local HIT testing pathway.
A systematic review showed the 4Ts score has a pooled negative predictive value of 99.8% for low scores, making it excellent for ruling out HIT. However, its positive predictive value for high scores is moderate (~50-64%), so confirmatory testing is still needed.